A Study to Measure the Effect of a Toothpaste Containing Proteins and Enzymes and a Fluoride Toothpaste on Gingival Health
1 other identifier
interventional
251
1 country
1
Brief Summary
This study is a double-blind, randomised, parallel group efficacy study. A minimum of 240 healthy female and male participants aged 18-70 years will be enrolled onto the study according to the inclusion/exclusion criteria. The accepted participants will then be randomly allocated to one of the two test products which they will use at home, twice a day for the duration of the study. Dental assessments of gingival condition and plaque level will be conducted after 4, 13 and 26 weeks of product use at the study site.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 29, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2019
CompletedFirst Submitted
Initial submission to the registry
April 9, 2025
CompletedFirst Posted
Study publicly available on registry
April 17, 2025
CompletedApril 17, 2025
April 1, 2025
6 months
April 9, 2025
April 9, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in gingival condition as measured by Gingival Index
The gingival condition was assessed using gingival index (GI) \[1\]. The scoring criteria were: 0 = Absence of inflammation; 1 = Mild inflammation - slight change in colour and little change in texture; 2 = Moderate inflammation - moderate glazing, redness, oedema, and hypertrophy (bleeding on pressure); 3 = Severe inflammation - marked redness and hypertrophy (tendency to spontaneous bleeding). Each eligible tooth was scored at six sites: facial (body, mesial, distal) and lingual (body, mesial, distal). The participant's score at each timepoint is the average of all tooth sites measured. \[1\] LOE H, SILNESS J. Acta Odontol Scand. 1963;21:533-551.
13 weeks
Secondary Outcomes (2)
Change in gingival condition as measured by Gingival Index
4 weeks and 26 weeks
Change in plaque levels as measured by Modified Quigley and Hein Plaque Index
4 weeks, 13 weeks and 26 weeks
Study Arms (2)
Test toothpaste
EXPERIMENTALToothpaste containing proteins, enzymes and 1450 ppm fluoride as sodium fluoride
Negative control toothpaste
ACTIVE COMPARATORToothpaste containing 1450 ppm fluoride as sodium fluoride
Interventions
Toothpaste containing proteins, enzymes and 1450 ppm fluoride as sodium fluoride
Toothpaste containing sodium fluoride at 1450 ppm F
Eligibility Criteria
You may qualify if:
- Be in good general health.
- Be willing and physically able to carry out all study procedures.
- Be willing and competent (verbally and cognitively) to give written informed consent and complete a medical history form.
- Have at least 20 natural teeth without subgingival calculus including 5 teeth (excluding 3rd molars) in each quadrant, which can be assessed.
- Have mean Gingival Index (GI) score between 1.0 and 2.0 (1.0 ≤ Mean GI ≤ 2.0) and mean Plaque Index (PI) ≥ 1.5 at screening and baseline.
- Not have had a scale and prophylaxis in the month prior to enrolment or have one scheduled prior to the end of the study.
- Be willing to use only the test products for 6 months, after brushing with the products on site.
- Brush teeth twice daily (once in the morning and once at night).
You may not qualify if:
- Pregnant or breast feeding mothers.
- Subjects who participated in gum health study within 3 months prior to screening.
- Current participation in any other cosmetic trials, any dental clinical trials or clinical trials.
- Subjects who have used gum health products in the 4 weeks prior to screening.
- Obvious signs of untreated caries or significant periodontal disease, which in the opinion of the study dentist, will affect either the scientific validity of the study or if the participant was to participate in the study would affect their wellbeing.
- Full or partial dentures wearers.
- Current orthodontic treatment.
- Smokers or those who have a recent smoking history, including e-cigarettes.
- Diabetics.
- Medical condition and/or regular use of any medication which might affect the outcome of the study, as determined by the study dentist, principally a course of anti-inflammatory, antimicrobial or statin drugs within 4 weeks of screening.
- Taking dietary supplements (e.g. multivitamins, antioxidants, fish oils, etc.).
- Vegetarians and Vegans.
- Allergic to any ingredient of study products.
- The subject is a Unilever employee or a member of the study team.
- Any participant who, in the judgement of the investigator, should not participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Unilever R&Dlead
Study Sites (1)
Hospital of Stomatology, Xi'an Jiaotong University
Xi'an, Shaanxi, 710004, China
Related Publications (1)
Hu X, Zhang P, Zhang L, Matheson JR, Lin S, Sun JN, Delfanti C, Tian J, Gupta AK, Vasantharaghavan R, Huang R. The effect of enzyme and protein containing toothpaste on gingival condition: a randomised controlled study. BMC Oral Health. 2025 Nov 3;25(1):1727. doi: 10.1186/s12903-025-07096-7.
PMID: 41184910DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Statistician
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 9, 2025
First Posted
April 17, 2025
Study Start
October 29, 2018
Primary Completion
April 30, 2019
Study Completion
April 30, 2019
Last Updated
April 17, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
Consent was not obtained from participants for this purpose.